← Eichor
Study identifier: NCT07296471 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Vitamin D Status and Multi-Omics Profiles in Primary Osteoporosis

Condition: Primary Osteoporosis  ·  Sponsor: Dr. Li Chen

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This observational study aims to explore the relationships between vitamin D status and genomic, proteomic, and metabolomic profiles in patients with primary osteoporosis. Eligible participants are adults who are newly diagnosed with primary osteoporosis at Yichang Second People's Hospital. Blood samples will be collected at the initial diagnosis to analyze gene expression, protein levels, and metabolic profiles. Participants will receive standard clinical treatment according to routine care, but no additional research sampling or follow-up will be performed. The study seeks to identify molecular patterns associated with osteoporosis and improve understanding of patient responses to therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Li Chen, MD  ·  +86-717-6741005  ·  chenli18995889811@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Yichang Second People's HospitalYichang, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07296471